| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/08/1994 | US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer |
| 02/08/1994 | US5284857 Substituted thienopyrans as antihypertensive agents |
| 02/08/1994 | US5284849 Renin inhibitors |
| 02/08/1994 | US5284841 Benzo-fused lactams promote release of growth hormone |
| 02/08/1994 | US5284839 Neuropeptide antagonist; renal and cerebral areas included |
| 02/08/1994 | US5284755 DNA encoding leukemia inhibitory factor receptors |
| 02/08/1994 | CA1326851C Oxadiazolyl-1,4-dihydropyridines and the analogues thereof |
| 02/07/1994 | CA2101901A1 Therapeutic heterocyclic derivatives |
| 02/06/1994 | CA2103655A1 Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present |
| 02/06/1994 | CA2101915A1 Tetrahydronaphthalene derivatives, their preparation and their application in therapy |
| 02/03/1994 | WO1994002510A2 Analogs of pth |
| 02/03/1994 | WO1994002493A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 02/03/1994 | WO1994002492A1 Novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds |
| 02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | WO1994002166A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | WO1994002150A1 Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity |
| 02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | CA2140760A1 Nutritional product for persons having a neurological injury |
| 02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
| 02/02/1994 | EP0580606A1 METHOD FOR DELIVERING DIRECT FEED MICROORGANISMS TO POULTRY $i(IN OVO) |
| 02/02/1994 | EP0478558B1 An improved process for the preparation of substituted isoflavone derivatives |
| 02/02/1994 | CN1023645C Novel resolution process for racemic spiro hydantoins |
| 02/01/1994 | US5283328 Free radical scavengers, antioxidants; treating diseases connected to aging |
| 02/01/1994 | US5283260 Method for reducing insulin resistance in mammals |
| 02/01/1994 | US5283254 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid derivatives |
| 02/01/1994 | US5283241 Animal growth regulators |
| 02/01/1994 | US5283058 Preventing the cytolysis of lymphocyte by alternating the antigen on donor's cell |
| 02/01/1994 | CA1326680C N-acyl-n-naphthoylglycines as aldose reductase inhibitors |
| 02/01/1994 | CA1326672C Dihydropyridines |
| 01/30/1994 | CA2101348A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 01/27/1994 | DE4223940A1 Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New acyclic amidine-containing diphosphonic acid derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580550A1 Oxamic acid derivatives as hypocholesteremic agents |
| 01/26/1994 | EP0580502A1 3-(Hydroxybenzylidenyl)-indoline-2-ones and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580079A1 Crosslinked, nitrogen-containing vinyl copolymers, process for their manufacture and use of these compounds |
| 01/26/1994 | EP0580078A1 Hydrophilic groups containing poly(vinylamine) derivatives, process for their manufacture and use thereof as pharmaceutical compounds, substrates for active substances and foodstuff ingredients |
| 01/26/1994 | EP0579915A1 Pharmaceutical composition containing a-cis- o 13-cis-retinoic acid or acitretin and a vitamin D derivative |
| 01/26/1994 | EP0579758A1 Parathyroid hormone receptor and dna encoding same |
| 01/26/1994 | EP0579733A1 Thiazolidinedione derivatives, production and use thereof |
| 01/26/1994 | EP0579650A1 Novel compounds |
| 01/26/1994 | EP0419504B1 Insulin analogues |
| 01/26/1994 | EP0408714B1 Heterocyclic sulphonylnitromethanes, process for their preparation and pharmaceutical compositions |
| 01/26/1994 | EP0400011B1 New phenylethanolamines |
| 01/26/1994 | EP0314781B1 Synthesis of glucagon homologs and therapeutic use thereof |
| 01/26/1994 | CA2140916A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 01/25/1994 | US5281748 N-substituted aminomethanediphosphonic acids |
| 01/25/1994 | US5281702 Di-N-deacetyl-lysogangliosides |
| 01/25/1994 | US5281592 Thiazine derivatives and preparation thereof |
| 01/25/1994 | US5281584 Effect of particle-size distribution of cellulose ethers on palatability of compositions |
| 01/25/1994 | US5281581 Treatment of insulin resistance |
| 01/25/1994 | US5281580 Respiratory system disorders |
| 01/25/1994 | US5281578 Pharmaceutical gallium metal complex in mixture with carrier |
| 01/25/1994 | US5281421 Tablet comprising gemfibrozil and surfactant having HLB value of 10 to 50 |
| 01/23/1994 | CA2101011A1 Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary |
| 01/23/1994 | CA2101010A1 Crosslinked, nitrogen-containing vinyl copolymers, processes for their preparation and the use of these compounds |
| 01/22/1994 | CA2100944A1 3-(hydroxybenzylidenyl)-indoline-2-ones, their preparation and the pharmaceutical compositions containing them |
| 01/20/1994 | WO1994001460A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 01/20/1994 | WO1994001420A1 Heterocyclic compounds as pharmaceutical |
| 01/20/1994 | WO1994001413A1 Boronated compounds |
| 01/20/1994 | WO1994001412A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| 01/20/1994 | WO1994001404A1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis |
| 01/20/1994 | WO1994001398A1 Vitamin d analogues |
| 01/20/1994 | WO1994001100A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/20/1994 | CA2139442A1 Heterocyclic compounds as pharmaceutical |
| 01/20/1994 | CA2139307A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| 01/20/1994 | CA2131631A1 Vitamin d analogues |
| 01/19/1994 | EP0579222A2 Lipid metabolism improving composition |
| 01/19/1994 | EP0578978A1 Dipeptide derivative and prophylactic or therapeutic agent for bone diseases containing same as active ingredient |
| 01/19/1994 | EP0578723A1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS |
| 01/19/1994 | EP0426804B1 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzene derivatives |
| 01/19/1994 | EP0382732B1 Superactive human insulin analogues |
| 01/19/1994 | EP0315687B1 (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin |
| 01/19/1994 | CN1080919A New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat) |
| 01/19/1994 | CN1080917A Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/18/1994 | US5280046 Using an amide containing phenol compound |
| 01/18/1994 | US5280033 Substituted 1-(alkoxy-iminoalkyl) imidazole derivatives and their use in treating disease related to an enhancement of thromboxane-A2 syntheis |
| 01/18/1994 | US5280017 Use of dextrin derivatives for the treatment of acidic conditions |
| 01/18/1994 | US5279832 Active-substance preparation for oral administration, especially to ruminants |
| 01/18/1994 | CA2099346A1 Lipid metabolism improving composition |
| 01/18/1994 | CA1326162C Low calorie fat substitute compositions resistant to laxative side effect |
| 01/12/1994 | EP0578521A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them |
| 01/12/1994 | EP0578494A1 24-cyclopropane vitamin D derivatives |
| 01/12/1994 | EP0578077A2 Compositions containing retinoic acids and tocopherol |
| 01/12/1994 | EP0577726A1 Fat substitute compositions having reduced laxative effects |
| 01/12/1994 | EP0577717A1 Artificial pancreatic perfusion device with temperature sensitive matrix |
| 01/12/1994 | EP0438531B1 Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
| 01/12/1994 | CN1080525A Pharmaceutical compositions |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278307 Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates |
| 01/11/1994 | US5278171 Anticholesterol, antilipemic agents |
| 01/11/1994 | US5278155 Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same |
| 01/11/1994 | US5278154 New vanadium complexes |
| 01/11/1994 | US5278153 Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase inhibitors and method |
| 01/11/1994 | US5278067 Culture product of microorganism Phoma |
| 01/11/1994 | US5277910 Process for the preparation of a pharmaceutical composition selectively lowering the blood-lipid level |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | US5277903 Treating ascites in human body |
| 01/11/1994 | CA2098550A1 Compositions containing retinoic acids and tocopherol |
| 01/11/1994 | CA1326025C 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation |
| 01/06/1994 | WO1994000558A1 DIABETOGENE rad: A TYPE II DIABETES SPECIFIC GENE |
| 01/06/1994 | WO1994000480A1 Steroidal glycosides for treating hypercholesterolemia |